Enveda
Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.
$311MSeries E
ParticipantI
ICONIQ
Activity from announced rounds
Activity in this selectionOct 17, 2026 · Jul 20, 2026
ICONIQ is an investment firm with a venture and growth business that backs technology founders from company formation through IPO and beyond.
Its venture and growth platform publishes operating research on growth, efficiency, hiring and the adoption of AI. Compass gives portfolio leaders access to proprietary benchmarks for comparing business metrics and identifying operating gaps.
The research goes into decisions such as structuring forward-deployed engineering teams, pricing implementation work and maintaining financial discipline as software businesses adopt AI. These are practical resources for founders building an organisation around a growing technology product.
Sources
- Rounds participated in
- 5
- Confirmed lead rounds
- 1 2 roles undisclosed
- New companies
- 5 First participation on record · 0 follow-on
- Funding in participating rounds
- $1.2B 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
5 in this selectionMedici Brands
Medici Brands builds and scales consumer food brands including David protein bars, shakes and frozen desserts, HallPass confectionery, and Epogee, a plant-based fat ingredient.
$250MSeries B
ParticipantRillet
Rillet provides accounting software in which finance teams and AI agents work from a shared general ledger.
$100MSeries C
LeadK2 Space
Manufactures large, high-power satellites.
$500MSeries D
Role not disclosedPaper
Design platform for the agentic era, enabling designers and engineers to collaborate through a shared language.
$34MSeries A
Role not disclosed